- 関
- vascular endothelial growth factor C
WordNet
- the 3rd letter of the Roman alphabet (同)c
- (music) the keynote of the scale of C major
- a general-purpose programing language closely associated with the UNIX operating system
PrepTutorEJDIC
- carbonの化学記号
- cesiumの化学記号
- cadmiumの化学記号
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/12/26 20:43:45」(JST)
[Wiki en表示]
Vascular endothelial growth factor C |
Rendering based on PDB 2X1W. |
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
2X1W, 2X1X, 4BSK
|
|
|
Identifiers |
Symbols |
VEGFC ; Flt4-L; VRP |
External IDs |
OMIM: 601528 MGI: 109124 HomoloGene: 3962 GeneCards: VEGFC Gene |
Gene ontology |
Molecular function |
• protein binding
• growth factor activity
• chemoattractant activity
• vascular endothelial growth factor receptor 3 binding
|
Cellular component |
• extracellular region
• extracellular space
• membrane
• platelet alpha granule lumen
|
Biological process |
• angiogenesis
• positive regulation of neuroblast proliferation
• platelet degranulation
• substrate-dependent cell migration
• signal transduction
• blood coagulation
• positive regulation of cell proliferation
• organ morphogenesis
• morphogenesis of embryonic epithelium
• platelet activation
• regulation of vascular endothelial growth factor receptor signaling pathway
• positive regulation of protein autophosphorylation
• response to drug
• positive regulation of blood vessel endothelial cell migration
• negative regulation of blood pressure
• vascular endothelial growth factor receptor signaling pathway
• positive regulation of epithelial cell proliferation
• positive regulation of protein secretion
• positive chemotaxis
• induction of positive chemotaxis
• positive regulation of cell division
• positive regulation of mast cell chemotaxis
• positive regulation of lymphangiogenesis
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
7424 |
22341 |
|
Ensembl |
ENSG00000150630 |
ENSMUSG00000031520 |
|
UniProt |
P49767 |
P97953 |
|
RefSeq (mRNA) |
NM_005429 |
NM_009506 |
|
RefSeq (protein) |
NP_005420 |
NP_033532 |
|
Location (UCSC) |
Chr 4:
177.6 – 177.71 Mb |
Chr 8:
54.08 – 54.19 Mb |
|
PubMed search |
[1] |
[2] |
|
|
Vascular endothelial growth factor C is a VEGF. The human gene encoding it is VEGFC.
The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in angiogenesis, lymphangiogenesis [1] and endothelial cell growth and survival, and can also affect the permeability of blood vessels. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-3 receptors. Only the fully processed form can bind and activate VEGFR-2 receptors. The structure and function of this protein is similar to those of vascular endothelial growth factor D (VEGF-D).[2]
Mutations in VEGFC cause Milroy disease .Balboa-Beltran, E; Fernández-Seara, M. J.; Pérez-Muñuzuri, A; Lago, R; García-Magán, C; Couce, M. L.; Sobrino, B; Amigo, J; Carracedo, A; Barros, F (2014). "A novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like disease". Journal of Medical Genetics 51 (7): 475–8. doi:10.1136/jmedgenet-2013-102020. PMID 24744435. edit
Pathological VEGF-C Expression
Lymphedema is caused by an imbalance between lymphatic vessel formation and absorption. Experimentally this can be created by overexpression of VEGF-C Lymphangioma: Overexpression of VEGF-C causes lymphatics to enlarge possibly facilitates metastasis.
References
- ^ "Oncogene: Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis".
- ^ "Entrez Gene: VEGFC vascular endothelial growth factor C".
Further reading
- Orpana A, Salven P (2003). "Angiogenic and lymphangiogenic molecules in hematological malignancies.". Leuk. Lymphoma 43 (2): 219–24. doi:10.1080/10428190290005964. PMID 11999550.
- Joukov V, Pajusola K, Kaipainen A, et al. (1996). "A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.". EMBO J. 15 (7): 1751. PMC 450088. PMID 8612600.
- Joukov V, Pajusola K, Kaipainen A, et al. (1996). "A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.". EMBO J. 15 (2): 290–98. PMC 449944. PMID 8617204.
- Paavonen K, Horelli-Kuitunen N, Chilov D, et al. (1996). "Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively.". Circulation 93 (6): 1079–82. doi:10.1161/01.cir.93.6.1079. PMID 8653826.
- Lee J, Gray A, Yuan J, et al. (1996). "Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.". Proc. Natl. Acad. Sci. U.S.A. 93 (5): 1988–92. doi:10.1073/pnas.93.5.1988. PMC 39896. PMID 8700872.
- Joukov V, Sorsa T, Kumar V, et al. (1997). "Proteolytic processing regulates receptor specificity and activity of VEGF-C.". EMBO J. 16 (13): 3898–911. doi:10.1093/emboj/16.13.3898. PMC 1170014. PMID 9233800.
- Fitz LJ, Morris JC, Towler P, et al. (1997). "Characterization of murine Flt4 ligand/VEGF-C.". Oncogene 15 (5): 613–8. doi:10.1038/sj.onc.1201191. PMID 9247316.
- Dunk C, Ahmed A (2001). "Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast.". Histol. Histopathol. 16 (2): 359–75. PMID 11332691.
- Dias S, Choy M, Alitalo K, Rafii S (2002). "Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy.". Blood 99 (6): 2179–84. doi:10.1182/blood.V99.6.2179. PMID 11877295.
- Ueda M, Terai Y, Yamashita Y, et al. (2002). "Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas.". Int. J. Cancer 98 (3): 335–43. doi:10.1002/ijc.10193. PMID 11920583.
- Witte D, Thomas A, Ali N, et al. (2002). "Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma.". Anticancer Res. 22 (3): 1463–6. PMID 12168824.
- Schoppmann SF, Birner P, Stöckl J, et al. (2002). "Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.". Am. J. Pathol. 161 (3): 947–56. doi:10.1016/S0002-9440(10)64255-1. PMC 1867252. PMID 12213723.
- Shin HY, Smith ML, Toy KJ, et al. (2002). "VEGF-C mediates cyclic pressure-induced endothelial cell proliferation". Physiol. Genomics 11 (3): 245–51. doi:10.1152/physiolgenomics.00068.2002. PMID 12388793.
- Yu DH, Wen YM, Sun JD, et al. (2003). "[Relationship among expression of vascular endothelial growth factor-C(VEGF-C), angiogenesis, lymphangiogenesis, and lymphatic metastasis in oral cancer]". Ai Zheng 21 (3): 319–22. PMID 12452004.
- Nakashima T, Kondoh S, Kitoh H, et al. (2003). "Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis". Int. J. Mol. Med. 11 (1): 33–9. doi:10.3892/ijmm.11.1.33. PMID 12469214.
- Tsai PW, Shiah SG, Lin MT, et al. (2003). "Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway". J. Biol. Chem. 278 (8): 5750–9. doi:10.1074/jbc.M204863200. PMID 12471041.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Masood R, Kundra A, Zhu S, et al. (2003). "Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops". Int. J. Cancer 104 (5): 603–10. doi:10.1002/ijc.10996. PMID 12594815.
- Ohno M, Nakamura T, Kunimoto Y, et al. (2004). "Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer". Oncol. Rep. 10 (4): 939–43. doi:10.3892/or.10.4.939. PMID 12792749.
Growth factors
|
|
Fibroblast |
FGF receptor ligands: |
- FGF1/FGF2/FGF5
- FGF3/FGF4/FGF6
|
|
KGF |
- FGF7/FGF10/FGF22
- FGF8/FGF17/FGF18
- FGF9/FGF16/FGF20
|
|
FGF homologous factors: |
|
|
hormone-like: |
|
|
|
EGF-like domain |
|
|
TGFβ pathway |
|
|
Insulin-like |
|
|
Platelet-derived |
|
|
Vascular endothelial |
- VEGF-A
- VEGF-B
- VEGF-C
- VEGF-D
- PGF
|
|
Other |
|
|
B trdu: iter (nrpl/grfl/cytl/horl), csrc (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd; path (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.
- Loffredo S1, Bova M1, Suffritti C2, Borriello F1, Zanichelli A2, Petraroli A1, Varricchi G1, Triggiani M3, Cicardi M2, Marone G1,4.
- Allergy.Allergy.2016 Jul;71(7):989-96. doi: 10.1111/all.12862. Epub 2016 Mar 17.
- BACKGROUND: Hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE) is a rare inherited genetic disease characterized by recurrent swelling episodes of the skin, gastrointestinal tract, and upper airways. Angioedema attacks result from increased vascular permeability due to the release of br
- PMID 26873113
- Prognostic significance of VEGF-C immunohistochemical expression in colorectal cancer: A meta-analysis.
- Zong S1, Li H2, Shi Q2, Liu S2, Li W3, Hou F4.
- Clinica chimica acta; international journal of clinical chemistry.Clin Chim Acta.2016 Jul 1;458:106-14. doi: 10.1016/j.cca.2016.04.037. Epub 2016 May 4.
- BACKGROUND: We sought to comprehensively summarize available evidence for the use of VEGF-C protein to evaluate the clinicopathological and prognostic role of VEGF-C in colorectal cancer.METHODS: Electronic databases from inception to February 2016 were used to search without language restrictions f
- PMID 27155587
- Leptin promotes proliferation and metastasis of human gallbladder cancer through OB-Rb leptin receptor.
- Zou H1, Liu Y2, Wei D1, Wang T1, Wang K1, Huang S1, Liu L1, Li Y1, Ge J1, Li X1, Zhu H1, Wang L1, Zhao S1, Zhang X1, Wang L1.
- International journal of oncology.Int J Oncol.2016 Jul;49(1):197-206. doi: 10.3892/ijo.2016.3530. Epub 2016 May 18.
- Emerging evidence has shown that leptin, an adipocyte-derived cytokine that is closely associated with obesity, play a significant role in carcinogenesis and tumorigenesis. However, its impact on gallbladder cancer (GBC) remains unclear. In this study, we firstly found that leptin and its functional
- PMID 27211817
Japanese Journal
- Chrysin Inhibits Lymphangiogenesis in Vitro
- Concurrent Expression of VEGF-C and Neuropilin-2 Is Correlated with Poor Prognosis in Glioblastoma
- Primary tumor-secreted lymphangiogenic factors induce pre-metastatic lymphvascular niche formation at sentinel lymph nodes in oral squamous cell carcinoma
Related Links
- 脈管形成や血管新生、リンパ管新生に関与する増殖因子にはVEGF-A、VEGF-B、 VEGF-C、VEGF-D、VEGF-D、VEGF-E、PlGF(胎盤増殖因子 placental growth factor)-1、PlGF-2の7つがあり、これらはまとめて「VEGFファミリー」と呼ばれる。単に VEGFと ...
Related Pictures
★リンクテーブル★
[★]
- 英
- vascular endothelial growth factor C、VEGF-C
- 関
- 血管内皮細胞増殖因子C
[★]
血管内皮増殖因子C、血管内皮細胞増殖因子C
- 関
- VEGF-C
[★]
[★]
血管内皮増殖因子 vascular endothelial growth factor
[★]
セシウム, caesium, cesium
[★]
カドミウム
- 関
- cadmium
[★]